Jim Cramer's Mad Money Lightning Round Picks, 7/24/07

by: Miriam Metzinger

Miriam Metzinger submits: Stocks discussed in the lightning round session of Jim Cramer’s Mad Money TV program, Tuesday July 24. Click on a stock ticker for more analysis:

Bullish calls:

CV Therapeutics (CVTX): 'Small-molecule biotech company, dedicated to solving one of the most pressing problems in the world, which is all the cardiology problems which can be solved, and I think that that is precisely the kind of stock to buy in this environment.'
Nastech Pharmaceutical (NSTK): 'Biotech's coming back. With a worldwide slowdown figured in...that's a winner!'
Discovery (NASDAQ:DISCA): 'Can you imagine a whole network with good programming that people tune in... that isn't about being stupid or lazy, or making people look awful, and humiliating them with reality shows?... How can it be?... Actually, I think it's really well-run. I think it goes higher. I think it could go to $27, so I would stay long, and maybe pull the trigger at $24.'
Apple (OTC:APPL): ' ... I would start adding... I do think that AAPL has come down enough to start rebuilding it, but not aggressively, because I need to see the quarter...'

Bearish calls:

MasterCard (NYSE:MA): 'Let MA come in, before we pull the trigger... Don't buy, don't buy. It's just a little too expensive for me right now...'
Trump Entertainment Resorts (TRMP): 'They could not sell themselves, so I don't even know what it's worth anymore... I've got to tell you, this is a distinctly bear market stock. I don't want to touch it... Management turnover... it's not for me...'
Navteq (NVT): 'We sell, sell, sell... we take off the gain, and we live to play again.'

Seeking Alpha publishes a summary of Jim Cramer's stock picks every day including: Mad Money Recap, Lightning Round, Stop Trading and Wall Street Confidential Picks.

Get Cramer's Picks by email -- it's free and takes only a few seconds to sign up.

Seeking Alpha is not affiliated with CNBC, Jim Cramer or TheStreet.com

About this article:

Want to share your opinion on this article? Add a comment.
Disagree with this article? .
To report a factual error in this article, click here